© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Zinc Supplement Use and Risk of Prostate Cancer
Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (MFL); Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (EG)
Correspondence to: Michael F. Leitzmann, MD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd., EPS-MSC 7232, Bethesda, MD 20892 (e-mail: leitzmann@mail.nih.gov)
| The first 10% of the full text of this article appears below. |
We read with interest the letter by Chang et al. reporting no association between zinc supplement use and the risk of prostate cancer in a Swedish case-control study. By comparison, our results (1) suggest that high intake of supplemental zinc is associated with an increased risk of advanced prostate cancer.
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 1108.